Peter Blume‐Jensen
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Oncology top 2%
- HER2/EGFR in Cancer Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 11
- Protein Kinase Regulation and GTPase Signaling 8
- Protein Degradation and Inhibitors 2
- Fibroblast Growth Factor Research 2
- Oncology 7
- HER2/EGFR in Cancer Research 3
- Co-authors
- Tony Hunter (4 shared papers)Guoqiang Jiang (2 shared papers)Ralf Janknecht (1 shared paper)Lars Rönnstrand (6 shared papers)Lena Claesson‐Welsh (3 shared papers)Zhimin Lu (1 shared paper)Carl‐Henrik Heldin (4 shared papers)Bengt Westermark (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)The EMBO Journal (2 papers)Neurogastroenterology & Motility (2 papers)Journal of Clinical Oncology (1 paper)Current Biology (1 paper)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Peter Blume‐Jensen
25 papers receiving 4.9k citations
Peter Blume‐Jensen's Hit Papers
Peers
Comparison fields: 5 of 115
- Immunology and Allergy 315
- Oncology 1.1k
- Molecular Biology 3.1k
- Hematology 447
- Immunology 795
Countries citing papers authored by Peter Blume‐Jensen
This map shows the geographic impact of Peter Blume‐Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Blume‐Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Blume‐Jensen more than expected).
Fields of papers citing papers by Peter Blume‐Jensen
This network shows the impact of papers produced by Peter Blume‐Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Blume‐Jensen. The network helps show where Peter Blume‐Jensen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Blume‐Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncogenic kinase signalling Hit paper breakdown → | 2001 | 2897 |
| 2 | 1998 | 308 | |
| 3 | 1991 | 279 | |
| 4 | 2001 | 279 | |
| 5 | 2000 | 271 | |
| 6 | 1999 | 177 | |
| 7 | 2010 | 134 | |
| 8 | 2014 | 105 | |
| 9 | 1993 | 99 | |
| 10 | 1994 | 86 | |
| 11 | 1995 | 83 | |
| 12 | Fibroblast growth factor receptor-1 regulation of Src family kinases. | 1995 | 80 |
| 13 | 2014 | 49 | |
| 14 | 1997 | 41 | |
| 15 | 2010 | 41 | |
| 16 | 1992 | 29 | |
| 17 | 2022 | 24 | |
| 18 | 2011 | 23 | |
| 19 | 2003 | 14 | |
| 20 | 2003 | 9 |
About Peter Blume‐Jensen
Peter Blume‐Jensen is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 5.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Mast cells and histamine (4 papers), HER2/EGFR in Cancer Research (3 papers), Protein Degradation and Inhibitors (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Fibroblast Growth Factor Research (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Immunology and Allergy (315 citations), Oncology (1.1k citations), Molecular Biology (3.1k citations), Hematology (447 citations) and Immunology (795 citations). Peter Blume‐Jensen has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Tony Hunter, Guoqiang Jiang, Ralf Janknecht, Lars Rönnstrand, Lena Claesson‐Welsh, Zhimin Lu, Carl‐Henrik Heldin, Bengt Westermark, KM Zsebo and Agneta Siegbahn. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal, Neurogastroenterology & Motility, Journal of Clinical Oncology and Current Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.